Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 351 clinical trials
DRAGON 1- Training Accreditation Implementation and Safety Evaluation of Combined PVE/HVE

Brief Summary: Some colorectal liver metastases can only be resected after inducing liver regeneration by portal vein embolization (PVE) to increase size function of the future liver remnant

  • 0 views
  • 09 Sep, 2021
  • 37 locations
Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer

The purpose of this study is to investigate whether preoperative hepatic and regional arterial chemotherapy are able to prevent liver metastasis and improve overall survival in patients

oxaliplatin
adenocarcinoma
floxuridine
adenocarcinoma of colon
liver metastasis
  • 5 views
  • 07 Nov, 2020
  • 1 location
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.

  • 0 views
  • 27 Jan, 2021
  • 1 location
Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

The role of surgical resection in the subset of patients with resectable hepatic metastases converted from initially non-resectable liver metastasis was still not clearly established. To

folfox regimen
metastasis
platelet count
liver metastasis
  • 9 views
  • 07 Nov, 2020
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

To investigate the efficacy of capecitabine combined with paclitaxel as neoadjuvant chemotherapy for gastric cancer with liver metastasis only

paclitaxel
liver metastasis
capecitabine
metastasis
xeloda
  • 16 views
  • 08 Nov, 2020
  • 1 location
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Protocol Synopsis Title A Humanitarian Device Exemption Use Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia Supplier BTG International Canada Inc. Type of Clinical Use Post-Marketing: TheraSphere commercially distributed under HDE # 980006 Objectives Provide supervised access to TheraSphere therapy at this institution Evaluate response to …

  • 0 views
  • 23 Jan, 2021
  • 1 location
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer

The purpose of this study is to investigate whether preoperative TAC is able to improve progression free survival and overall survival in patients receiving liver metastasis resection of

metastasis
liver metastasis
  • 16 views
  • 07 Nov, 2020
  • 1 location
Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers

patients with hepatic metastasis from colorectal cancer after surgical resection is approximately 30 %. However, most hepatic metastases from colorectal cancer were inoperable. With the progress

oxaliplatin
adenocarcinoma
adjuvant therapy
fluorouracil
liver metastasis
  • 4 views
  • 07 Nov, 2020
Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning

The purpose of this study is to evaluate the effect of primary tumor resection on the metabolic activity of metastases in patients with a colorectal primary tumor and synchronous liver

metastasis
liver metastasis
  • 12 views
  • 07 Nov, 2020
  • 1 location
Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers

The purpose of this study is to evaluate the safety of liver resection for metastatic, resectable lesions from colorectal cancers after systemic chemotherapy.

liver disease
adenocarcinoma
oxaliplatin
liver metastasis
modified folfox6 regimen
  • 10 views
  • 07 Nov, 2020
  • 1 location